Tumor progression via downstream activation of the PI3K/AKT/mammalian target of rapamycin (mTOR) signaling cascade is thereby induced and further promoted by viral oncoproteins E5, E6 and E7 in HPV-associated malignancies [114]. Here, MTOR is linked to neoplasm.